Cargando…
Serum MicroRNA-137 Serves as a Novel Biomarker for Cerebral Atherosclerosis Diagnosis and Cerebrovascular Event Prediction
MicroRNAs have been reported as biomarkers for various diseases, including cerebral atherosclerosis (AS). In this study, whether serum microRNA-137 (miR-137) could be used as a biomarker for diagnosing cerebral AS and predicting cerebrovascular event was investigated. Quantitative real-time PCR was...
Autores principales: | Xuan, Jingjing, Shang, Meiling, Li, Xuelian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340946/ https://www.ncbi.nlm.nih.gov/pubmed/34050091 http://dx.doi.org/10.1097/FJC.0000000000001058 |
Ejemplares similares
-
Serum microRNA Profiles Serve as Novel Biomarkers for Autoimmune Diseases
por: Jin, Fangfang, et al.
Publicado: (2018) -
Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease
por: Dong, Hui, et al.
Publicado: (2015) -
MicroRNAs as Potential Biomarkers in Atherosclerosis
por: Churov, Alexey, et al.
Publicado: (2019) -
A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023) -
Circulating MicroRNAs from Serum Exosomes May Serve as a Putative Biomarker in the Diagnosis and Treatment of Patients with Focal Cortical Dysplasia
por: Chen, Shang-Der, et al.
Publicado: (2020)